Emergency Medicine

Home Emergency Medicine
Before completing clinical trials to ensure the vaccine is safe and effective

Russia Approves COVID-19 Vaccine Before Trials Completed

President Vladimir Putin claims the vaccine 'works effectively enough'
Emergency department visits for acute respiratory illness among Medicare beneficiaries significantly increase in the days before major thunderstorms

Respiratory-Related ED Visits Up in Days Before Thunderstorms

Findings seen among Medicare beneficiaries, particularly those with asthma, COPD, or both
Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment

Gilead Seeks FDA Approval for Remdesivir

Trials of the drug show that it can cut recovery time from COVID-19 by nearly a third
Stephen Hahn

FDA Head Says Any Approved COVID-19 Vaccine Will Be Safe

Assurance was given during a video briefing with the American Medical Association
The rates of severe acute respiratory syndrome coronavirus 2 infection are increased among minority and socioeconomically disadvantaged children

SARS-CoV-2 Rates Up for Minority, Disadvantaged Children

Increased rates of infection for non-Hispanic black, Hispanic children, those in lower quartiles of MFI
The U.S. Food and Drug Administration is warning consumers not to use onions recalled by Thomson International Inc. as they may be contaminated with Salmonella

FDA: Outbreak of Salmonella Infections Linked to Onions

In the United States, 640 cases have been reported, including 85 hospitalizations
With millions of American children soon returning to school

Report: 97,000 U.S. Children Infected With COVID-19 in Late July

States in the South and West accounted for more than seven of 10 infections
Two-thirds of U.S. adults say they would get a COVID-19 vaccine

Two-Thirds of U.S. Adults Likely to Get COVID-19 Vaccine

However, likelihood varies by geography, race, and other demographic factors
During the early COVID-19 period

Hospitalization Rates for AMI Dropped During Early COVID-19

Reduction at rate of 19.0 cases per week followed by increase at rate of 10.5 cases per week
For patients with gonorrhea

Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin

Efficacy of single-dose oral ciprofloxacin treatment in the per-protocol population was 100 percent